TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor–mediated inflammatory responses

Yusuke Miyashita(Kumamoto University), Hiroyuki Oshiumi(Kumamoto University)
Life Science Alliance
November 24, 2021
Cited by 16


Related Papers